New Zealand markets open in 2 hours 53 minutes

Thermo Fisher Scientific Inc. (TMO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
503.48+0.69 (+0.14%)
As of 02:06PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
5,721,000
6,950,000
7,725,000
6,375,000
3,696,000
Depreciation & amortisation
3,400,000
3,381,000
2,592,000
2,325,000
2,277,000
Deferred income taxes
-722,000
-995,000
-406,000
-552,000
-348,000
Stock-based compensation
302,000
307,000
230,000
196,000
181,000
Change in working capital
-1,535,000
-1,049,000
-1,558,000
-395,000
-619,000
Accounts receivable
-
-430,000
-204,000
-1,302,000
-225,000
Inventory
-
-825,000
-1,065,000
-508,000
-458,000
Accounts payable
-
648,000
479,000
59,000
266,000
Other working capital
5,854,000
6,911,000
7,020,000
6,815,000
4,047,000
Other non-cash items
522,000
857,000
1,187,000
536,000
449,000
Net cash provided by operating activities
7,693,000
9,154,000
9,543,000
8,289,000
4,973,000
Cash flows from investing activities
Investments in property, plant and equipment
-1,839,000
-2,243,000
-2,523,000
-1,474,000
-926,000
Acquisitions, net
-2,750,000
-39,000
-19,395,000
-38,000
-1,843,000
Other investing activities
-86,000
99,000
-34,000
-6,000
118,000
Net cash used for investing activities
-4,655,000
-2,159,000
-21,932,000
-1,510,000
-1,487,000
Cash flows from financing activities
Debt repayment
-2,641,000
-4,065,000
-11,738,000
-1,100,000
-9,824,000
Common stock issued
-
-
-
-
153,000
Common stock repurchased
-4,000,000
-3,000,000
-2,000,000
-1,500,000
-1,500,000
Dividends paid
-487,000
-455,000
-395,000
-337,000
-297,000
Other financing activities
12,000
-9,000
-91,000
-147,000
-69,000
Net cash used provided by (used for) financing activities
-1,809,000
-2,810,000
6,581,000
959,000
-3,118,000
Net change in cash
1,248,000
4,046,000
-5,845,000
7,914,000
305,000
Cash at beginning of period
1,905,000
4,491,000
10,336,000
2,422,000
2,117,000
Cash at end of period
3,134,000
8,537,000
4,491,000
10,336,000
2,422,000
Free cash flow
Operating cash flow
7,693,000
9,154,000
9,543,000
8,289,000
4,973,000
Capital expenditure
-1,839,000
-2,243,000
-2,523,000
-1,474,000
-926,000
Free cash flow
5,854,000
6,911,000
7,020,000
6,815,000
4,047,000